Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape from combination monoclonal antibody treatment is rarely reported. We describe an immunocompromised individual with human immunodeficiency virus and persistent SARS-CoV-2 infection in whom substantial SARS-CoV-2 evolution occurred, including the emergence of 2 mutations associated with escape from the monoclonal antibody cocktail received.
| Original language | English (US) |
|---|---|
| Article number | ofad054 |
| Journal | Open Forum Infectious Diseases |
| Volume | 10 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 1 2023 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- HIV
- SARS-CoV-2
- immunocompromised
- monoclonal antibody
- virus evolution
ASJC Scopus subject areas
- Oncology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Severe Acute Respiratory Syndrome Coronavirus 2 Evolution and Escape from Combination Monoclonal Antibody Treatment in a Person with HIV'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS